Home / Services / Behavioral Health

Behavioral Health

5.0

94+ Reviews

What if you took care of your mind as well as you take care of your body? From addiction therapy to psychotherapy to medication management, we offer everything you need to regain control. Say goodbye to the symptoms of depression, anxiety, bipolar disorder, ADHD, PTSD and more – and uncover the life that you deserve.

Ongoing Medication Management
Addiction Therapy and Prescription Treatments
Medically-Supervised Psychedelic Therapy

Book Now
Behavioral Health

Begin your journey today.

In three easy steps, you can be on the road to feeling happier and healthier.

1Discuss

Discuss your options.

Complete an intake questionnaire and undergo a comprehensive personal health assessment to determine if ketamine-assisted therapy is the best path forward.

2Plan

Build a plan.

Get paired with a personal mental health specialist to ensure the therapy will be both safe and effective - and to build a personalized plan based on your unique goals and expectations.

3Ok Bro

Start feeling better.

Return for an immersive and transformative experience in a private and serene space, where you’ll be monitored closely from start to finish and emerge a better version of yourself.

40M+

adults (19.1% of the US population) suffer from anxiety disorders.

63.1%

of those suffering do not receive treatment.

3/10

of U.S. adults have been diagnosed with depression in their lifetime.

Lets Get Started

The program has a consultation fee of $400 and session fee of $500.

Book a Consultation

Consultation

1-hour consultation to ensure you are the right fit for ketamine-assisted therapy.

Consultation

$400

The consultation fee is $400, which is standard pricing for an hour of evaluation by a mental health professional. We require this consultation in order to ensure that the treatment will be safe and effective – and to ensure that you reach your personal goals.

Session

A 2-hour session of guided ketamine-assisted therapy.

Mental Health

$500

Once you are approved for treatment, you will be eligible to schedule 1-hour sessions for a fee of $500 per session. Sessions are generally purchased in blocks of four, but we can accommodate your needs depending on your specific goals - there is no limit to the number of sessions you can purchase.

Meet Our Providers

Michael Genovese, MD, JD

Psychiatry

Michael Genovese is a board-certified psychiatrist with 20 years of experience. He has served in inpatient and outpatient settings and...

Arjun Viswanathan, NP

Psychiatric Nurse Practitioner

Arjun Viswanathan is a psychiatric/mental health nurse practitioner and registered nurse. Mr. Arjun Viswanathan has 6 years of experience as...

Can't pay today? We've got you.

Everyone deserves to feel happy in their own skin.

Feeling great and the confidence that comes from it should be within everyone’s reach, regardless of their current financial situation. That’s why we’re proud to offer financing options that allow you to feel better now - but pay later - so you can get a head start on happiness and health. It’s been long enough.

Click here to learn more about our Buy Now, Pay Later options, because there's no reason to wait for the wellness that you deserve.

Patient Testimonials

360,000+

Tests Performed

157,700+

Patients Treated

30,000+

Monthly Online Visits

2,000+

Monthly Bookings

Frequently Asked Questions

Ketamine is extremely safe – it has been used in childhood anesthesia for decades. Ketamine is the only psychedelic approved for therapeutic use in the U.S. Ketamine is a preferred anesthetic – from the battlefield to the operating room – because of its proven safety.⁷ In fact, it was first introduced as a safer alternative to other anesthetics. When used for therapy, only a small fraction of the anesthetic dosage is used.

Although it can cause psychological dependence, ketamine does not cause immediate physical dependence or addiction.⁸ During your journey, our experts will monitor for signs of dependence and adjust your treatment plan accordingly. They’ll also monitor for the presence of side effects (generally limited to nausea, vomiting and agitation) which generally occur in less than 5% of patients; ketamine generally does not produce the side effects found in anti-anxiety medications and antidepressants.⁹

In trial after trial, evidence-based research has shown ketamine to be effective and safe, with minimal side effects or adverse reactions.¹⁰ And don’t worry, all of our sessions are medically supervised – you’ll be monitored throughout the process for any indication of discomfort.

Absolutely, the numbers provide clear evidence of this.*

Ketamine has been shown to drastically improve the symptoms of depression and anxiety – more effectively than talk therapy, psychotherapy and SSRI antidepressants. Studies show that ketamine leads to success in nearly 70% of treatment-resistant depression cases¹¹ – often in just a few hours – and reduces suicidal ideation and self-harm.¹²

Positive, joyous and clear.

A deeply relaxed sense of being elsewhere.

Peaceful, insightful and with a renewed sense of self-awareness.

A sustained sense of clarity, motivation and satisfaction.

Ketamine reduces activity in the medial frontoparietal network (also known as the default mode network, or DMN.) This part of the brain is active when we are passive – not focused on any particular goal. It is also associated with introspection, activating when we reflect upon ourselves or criticize our own behavior.¹³

As the connectivity of the DMN changes, you’ll be able to break through the patterns of thinking that lead to depression, anxiety, alcoholism, etc. As other areas of the brain continue to function during the DMN’s reduced activity, they may experience a newfound cohesion and synchronization – or clarity.

Ketamine also promotes neuroplasticity – your brain’s ability to change and adapt – and triggers synaptogenesis – the creation of new pathways in the brain.¹⁴

As the connections between neurons decrease, it becomes harder to find motivation, joy, hope, equanimity and gratitude. By facilitating the repair and reorganization of these connections– along with fueling new connections – ketamine optimizes the neural pathways, allowing you to transcend ingrained patterns of thought.

By acting on the brain, ketamine works on the mind – it softens the volume of mental chatter that we hear by default. This stream of inner sound seems to appear by itself, like a reflex – it’s automatic patterns of thought drive anxiety and fuel depression.

Ketamine opens the space to build new beliefs, habits and patterns of behavior – this space is the freedom to plant seeds for positive change.

  • This space brings a new light to the struggles of the past and present, allowing you to witness and process your traumas and emotional reactions directly – rather than be their victim.

  • Here, you’ll find the courage to step into memories that would normally be avoided. You’ll reframe your self-awareness and glimpse into the root causes of your discomfort.

By disconnecting from previous modes of thinking, you’ll disconnect from the underlying causes of mental illness. You’ll experience a state of consciousness that is different from your normal state – one that will provide a new perspective on yourself, your obstacles and how to overcome them. You’ll find the ability to create new patterns of thought – ones that do not produce anxiety or depression – so that you can rebuild your own personal narrative into the ideal you. Along with structured therapy, you’ll see yourself and your life experiences in a new light – and move past the emotional hurdles that hold you back.

Do you have depression or anxiety that is treatment-resistant? Do you wish to experience the transformative effects of ketamine in a safe and comfortable space? If you’ve ever experienced bouts of depression, anxiety, PTSD, or other mental health issues, ketamine may offer the help you need.

While almost anyone can benefit from this treatment, there are some conditions that are not compatible with ketamine-assisted therapy. For example, if you have uncontrolled hypertension, history of schizophrenia or psychosis, are pregnant or have a recent head injury, you may not be eligible for this treatment. Our providers will discuss your medical history in detail during the intake process to ensure this treatment is right for you.

* Results may vary and are not guaranteed

1. Anxiety Disorders | NAMI: National Alliance on Mental Illness. www.nami.org/About-Mental-Illness/Mental-Health-Conditions/Anxiety-Disorders.

2. Facts and Statistics | Anxiety and Depression Association of America, ADAA. adaa.org/understanding-anxiety/facts-statistics.

3. Witters, By Dan. “U.S. Depression Rates Reach New Highs.” Gallup.com, 13 Sept. 2023, news.gallup.com/poll/505745/depression-rates-reach-new-highs.aspx.

4. Mandal, Suprio, et al. “Efficacy of Ketamine Therapy in the Treatment of Depression.” Indian Journal of Psychiatry, vol. 61, no. 5, Medknow, Dec. 2018, p. 480, doi:10.4103/psychiatry.indianjpsychiatry_484_18.

5. Hull, Thomas D., et al. “At-home, Sublingual Ketamine Telehealth Is a Safe and Effective Treatment for Moderate to Severe Anxiety and Depression: Findings From a Large, Prospective, Open-label Effectiveness Trial.” Journal of Affective Disorders, vol. 314, Elsevier BV, Oct. 2022, pp. 59–67, doi:10.1016/j.jad.2022.07.004.

6. Krupitsky, Evgeny, and A. Y. Grinenko. “Ketamine Psychedelic Therapy (KPT): A Review of the Results of Ten Years of Research.” Journal of Psychoactive Drugs, vol. 29, no. 2, Taylor and Francis, May 1997, pp. 165–83, doi:10.1080/02791072.1997.10400185.

7. De Rocquigny, G., et al. “Use of Ketamine for Prehospital Pain Control on the Battlefield: A Systematic Review.” The Journal of Trauma and Acute Care Surgery, vol. 88, no. 1, Lippincott Williams and Wilkins, Oct. 2019, pp. 180–85, doi:10.1097/ta.0000000000002522.

8. Drug Fact Sheet: Ketamine. https://www.dea.gov/sites/default/files/2020-06/Ketamine-2020.pdf. Accessed 17 Sept. 2023.

9. Taylor & Francis. “Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine With Psychotherapy.” Taylor & Francis, www.tandfonline.com/doi/full/10.1080/02791072.2019.1587556.

10. McInnes, L. Alison, et al. “A Retrospective Analysis of Ketamine Intravenous Therapy for Depression in Real-world Care Settings.” Journal of Affective Disorders, vol. 301, Elsevier BV, Mar. 2022, pp. 486–95, doi:10.1016/j.jad.2021.12.097.

Schenberg, Eduardo Ekman. “Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.” Frontiers in Pharmacology, vol. 9, Frontiers Media, July 2018, doi:10.3389/fphar.2018.00733.

Rot, Marije Aan Het, et al. “Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression.” Biological Psychiatry, vol. 67, no. 2, Elsevier BV, Dec. 2009, pp. 139–45, doi:10.1016/j.biopsych.2009.08.038.

Fava, Maurizio, et al. “Double-blind, Placebo-controlled, Dose-ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-resistant Depression (TRD).” Molecular Psychiatry, vol. 25, no. 7, Nature Portfolio, Oct. 2018, pp. 1592–603, doi:10.1038/s41380-018-0256-5.

Glue, Paul, et al. “Safety and Efficacy of Maintenance Ketamine Treatment in Patients With Treatment-refractory Generalised Anxiety and Social Anxiety Disorders.” Journal of Psychopharmacology, vol. 32, no. 6, SAGE Publishing, Mar. 2018, pp. 663–67, doi:10.1177/0269881118762073.

11. Köhler, Stephan, and Felix Betzler. “Ketamin – Eine Neue Option in Der Behandlung Der Therapieresistenten Depression.” Fortschritte Der Neurologie Psychiatrie, vol. 83, no. 02, Thieme Medical Publishers (Germany), Feb. 2015, pp. 91–97, doi:10.1055/s-0034-1398967.

12. Dadiomov, David, and Kelly C. Lee. “The Effects of Ketamine on Suicidality Across Various Formulations and Study Settings.” The Mental Health Clinician, vol. 9, no. 1, Dec. 2018, pp. 48–60, doi:10.9740/mhc.2019.01.048.

13. Lehmann, Michael, et al. “Differential Effects of Rumination and Distraction on Ketamine Induced Modulation of Resting State Functional Connectivity and Reactivity of Regions Within the Default-mode Network.” Social Cognitive and Affective Neuroscience, vol. 11, no. 8, University of Oxford, Apr. 2016, pp. 1227–35, doi:10.1093/scan/nsw034.

14. Aleksandrova, Lily R., and Anthony G. Phillips. “Neuroplasticity as a Convergent Mechanism of Ketamine and Classical Psychedelics.” Trends in Pharmacological Sciences, vol. 42, no. 11, Elsevier BV, Oct. 2021, pp. 929–42, doi:10.1016/j.tips.2021.08.003.

Chen, Jennifer. “How Ketamine Drug Helps With Depression.” Yale Medicine, Mar. 2022, www.yalemedicine.org/news/ketamine-depression.